These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34962105)

  • 1. Primary thyroid high-grade B-cell lymphoma with MYC and BCL2 rearrangements in Hashimoto's thyroiditis.
    Tariq H; Zahra U
    Diagn Cytopathol; 2022 Feb; 50(2):84-85. PubMed ID: 34962105
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous Regression of High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements: Case Report and Literature Review.
    Stanoszek LM; Smith LB; Grajewski K; Reneau JC; Wilcox R; Perry AM
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e120-e125. PubMed ID: 33060050
    [No Abstract]   [Full Text] [Related]  

  • 3. Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes.
    Lue JK; Luttwak E; Rivas-Delgado A; Irawan H; Boardman A; Caron PC; David K; Epstein-Peterson Z; Falchi L; Ghione P; Hamlin P; Horwitz SM; Intlekofer AM; Johnson W; Kumar A; Moskowitz A; Noy A; Palomba ML; Steiner R; Stuver R; Torka P; Vardhana S; Zelenetz AD; Schoder H; Imber B; Yahalom J; Zhang Y; Galera P; Dogan A; Aypar U; Salles G
    Blood Cancer J; 2024 Oct; 14(1):178. PubMed ID: 39402034
    [No Abstract]   [Full Text] [Related]  

  • 4. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
    Li S; Weiss VL; Wang XJ; Desai PA; Hu S; Yin CC; Tang G; Reddy NM; Medeiros LJ; Lin P
    Am J Surg Pathol; 2016 Feb; 40(2):253-61. PubMed ID: 26448193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade B-cell lymphoma with MYC and BCL2 rearrangements presenting as a cervical mass.
    Lin C; Kuma L; Shen L
    Pathology; 2024 Jun; 56(4):588-590. PubMed ID: 37940480
    [No Abstract]   [Full Text] [Related]  

  • 6. High-grade B-Cell Lymphoma With MYC, BCL2, and/or BCL6 Translocations/Rearrangements: Clinicopathologic Features of 51 Cases in a Single Institution of South China.
    Zhang J; Weng Z; Huang Y; Li M; Wang F; Wang Y; Rao H
    Am J Surg Pathol; 2020 Dec; 44(12):1602-1611. PubMed ID: 32991338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating a false-negative
    Peterson JF; Pitel BA; Smoley SA; Vasmatzis G; Smadbeck JB; Greipp PT; Ketterling RP; Macon WR; Baughn LB
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-positive low-grade follicular lymphoma transforming to EBV-negative high-grade B-cell lymphoma with MYC and BCL2 rearrangements.
    Nam MH; Hsieh YY; Chen BJ
    Pathology; 2022 Aug; 54(5):634-636. PubMed ID: 34872752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clonal B-cell reaction in Sjögren disease and Hashimoto autoimmune thyroiditis].
    Tiemann M; Asbeck R; Wacker HH
    Pathologe; 1996 Jul; 17(4):289-95. PubMed ID: 8927595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
    Lee J; Hasteh F
    Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thyroid carcinoma and Hashimoto thyroiditis].
    Intidhar Labidi S; Chaabouni AM; Kraiem T; Attia N; Gritli S; El May A; Ben Slimane F
    Ann Otolaryngol Chir Cervicofac; 2006 Sep; 123(4):175-8. PubMed ID: 17088704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYC/BCL2 double-hit high-grade B-cell lymphoma.
    Li S; Lin P; Young KH; Kanagal-Shamanna R; Yin CC; Medeiros LJ
    Adv Anat Pathol; 2013 Sep; 20(5):315-26. PubMed ID: 23939148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma.
    Takeoka K; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Hayashida M; Ohno H
    Ann Hematol; 2021 Dec; 100(12):3043-3045. PubMed ID: 32895753
    [No Abstract]   [Full Text] [Related]  

  • 16. EBV-positive high-grade B-cell lymphoma with MYC and BCL6 rearrangements.
    Craig A; Wen KW
    Blood; 2022 Jul; 140(4):406. PubMed ID: 35900784
    [No Abstract]   [Full Text] [Related]  

  • 17. Coexistence of papillary carcinoma and Hashimoto's thyroiditis.
    Matesa-Anić D; Matesa N; Dabelić N; Kusić Z
    Acta Clin Croat; 2009 Mar; 48(1):9-12. PubMed ID: 19623865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic replacement infiltrates in cystic Hashimoto's thyroiditis: a potential diagnostic pitfall.
    Geisinger KR; Hartle EO; Warren T
    Endocr Pathol; 2014 Sep; 25(3):332-8. PubMed ID: 24639138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two new high-grade B-cell lymphoma cell lines with MYC and BCL2 rearrangements that are suitable for in vitro drug sensitivity studies.
    Dheur MS; Poirel HA; Ameye G; Tilman G; Saussoy P; Defour JP; Camboni A; Van Den Neste E; Coulie PG; van Baren N
    Leuk Lymphoma; 2019 Apr; 60(4):1043-1052. PubMed ID: 30277098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next generation sequencing reveals high mutation frequency of
    Evrard SM; Péricart S; Grand D; Amara N; Escudié F; Gilhodes J; Bories P; Traverse-Glehen A; Dubois R; Brousset P; Parrens M; Laurent C
    Haematologica; 2019 Apr; 104(4):e154-e157. PubMed ID: 30309852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.